Faculty profile
Francisco Vera-Badillo
Back to facultyResearch
Read how they describe their research on their Queen's University profile.
Latest papers
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
The Lancet Oncology · 2023
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
The New England journal of medicine · 2019
Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study.
World journal of urology · 2017
4 publications.
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
Sweeney CJ, Martin AJ, Stockler MR, Begbie S, Cheung L, N K, Chowdhury S, Frydenberg M, Horvath LG, Joshua AM
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ, ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study.
Siemens DR, Jaeger MT, Wei X, Vera-Badillo F, Booth CM
Relevance of randomised controlled trials in oncology.
Tannock IF, Amir E, Booth CM, Niraula S, Ocana A, Seruga B, Templeton AJ, Vera-Badillo F
Frequent collaborators
- Antonio Finelli and Ricardo Rendon: 100 shared papers
- Sebastien Hotte and Kim Chi: 90 shared papers
- Kim Chi and Krista Noonan: 44 shared papers
- Sebastien Hotte and Ricardo Rendon: 21 shared papers
- Sebastien Hotte and Krista Noonan: 18 shared papers
- Sebastien Hotte and Antonio Finelli: 17 shared papers
- Kim Chi and Wendy Parulekar: 13 shared papers
- Kim Chi and Ricardo Rendon: 13 shared papers
- Eitan Amir and Saroj Niraula: 13 shared papers
- Antonio Finelli and Kim Chi: 12 shared papers
- Sebastien Hotte and Wendy Parulekar: 9 shared papers
- Krista Noonan and Ricardo Rendon: 9 shared papers
- Wendy Parulekar and Ricardo Rendon: 4 shared papers
- Wendy Parulekar and Francisco Vera-Badillo: 2 shared papers
- Sebastien Hotte and Francisco Vera-Badillo: 1 shared paper
- Antonio Finelli and Francisco Vera-Badillo: 1 shared paper
- Kim Chi and Francisco Vera-Badillo: 1 shared paper
- Wendy Parulekar and Eitan Amir: 1 shared paper
- Krista Noonan and Francisco Vera-Badillo: 1 shared paper
- Eitan Amir and Francisco Vera-Badillo: 1 shared paper
- Saroj Niraula and Francisco Vera-Badillo: 1 shared paper
- Ricardo Rendon and Francisco Vera-Badillo: 1 shared paper
- Department of Oncology
- Department of Urologic Sciences
- Department of Surgery
- Department of Medicine
- Department of Urology
- Other
Co-authors at Queen's University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Wendy Parulekar
Department of Oncology
2 shared papers, latest 2023
Anthony Joshua
Faculty
1 shared papers, latest 2019
Antonio Finelli
Department of Surgery
1 shared papers, latest 2023
Kim Chi
Department of Urologic Sciences
1 shared papers, latest 2019
Eric Vigneault
Faculty
1 shared papers, latest 2023
Krista Noonan
Department of Urologic Sciences
1 shared papers, latest 2023
Eitan Amir
Department of Medicine
1 shared papers, latest 2016
Saroj Niraula
Faculty
1 shared papers, latest 2016
Sebastien Hotte
Department of Oncology
1 shared papers, latest 2023
Ricardo Rendon
Department of Urology
1 shared papers, latest 2023
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.